Guanylhydrazones have shown promising antitumor activity in preclinical tumor models in several studies.
Guanylhydrazones represent a class of compounds showing interesting pharmacological activities on several levels; they derive from the same aminoguanidine chemotype with mixed hydrogen bond acceptor and donor properties as well as being able to establish electrostatic interactions (1, 2) . Moreover, they already led to various active derivatives, as illustrated in Fig. 1 (3) . Guanidine derivatives have been reported to be effi cient anti-cancer agents. Previous reports showed that m-iodobenzylguanidines (MIBG), pyridylcyanoguanidine (CHS 828) and mitoguazone (MGBG) have shown promising antitumor activity in preclinical tumor models, while mitoguazone showed useful clinical activity for the treatment of malignant lymphoma, carcinoma of the head, neck and esophageal and non-small cell lung cancer (4) . More recently, a series of imidazo [2,1-b] thiazoleguanylhydrazones was reported for their antitumor activity and was able to induce apoptosis in HT29 and HL-60 cell lines (5). However, no structure-activity relationship of imidazothiazole compounds was available. Sixteen guanylhydrazone coactivator binding inhibitors for estrogen receptor showed good to moderate activity, but no cytotoxicity data were shown for these compounds (6). Aft er identifi cation of the guanidine moiety, as the key pharmacophoric group for activity, we decided to replace the imidazothiazole ring by a phenyl ring, which off ered the advantage of scaff old modifi cation. In particular, our objective was to perform a systematic exploration of the aryl group allowing introduction of various substituents at the phenyl ring. The phenyl ring was replaced by heteroaromatics in another series of compounds.
EXPERIMENTAL

General
All purchased chemical reagents (Sigma-Aldrich, Brazil) were of the highest purity. 
Synthesis of target compounds
Guanylhydrazones 1-20 were prepared by the reaction of an appropriate aryl aldehyde with aminoguanidine hydrochloride (1:1.25 equiv). The reactants were dissolved in a minimal amount of methanol, heated to refl ux, and stirred overnight. Upon cooling to room temperature, products crystallized out from the methanol solution. Products were recovered and dried under vacuum overnight. All reactions were monitored by TLC. The solvent was removed under reduced pressure and the solid was triturated with ethyl acetate yielding the substances as powders. . Aft er 3 hours, the formazan product was dissolved in 150 mL DMSO and the absorbance was measured using a multiplate reader (DTX 880 Multimode Detector, Beckman Coulter). The substance eff ect was quantifi ed as the percentage of control absorbance at 595 nm.
Assessment of cell viability
Macrophage J774 cells were seeded (10 5 cells per well) in 96-well fl at-bott om microplates. The cells were maintained for 2 hours at 37 °C, 5 % CO 2 and the medium was replaced with diff erent concentrations of the drugs (10, 100 and 1000 mmol L -1 ), in duplicate, and exposed for another 24 hours. Growth controls were also included. Aft erwards, MTT solution was added to the cells and plates were returned to the incubator for another 4 hours to evaluate cell viability. This was followed by washing of the wells with 150 mL of DMSO for 15 minutes and measurement was performed spectrophotometrically at 540 nm.
RESULTS AND DISCUSSION
Guanylhydrazone derivatives were obtained through the condensation reaction of benzaldehyde derivatives with aminoguanidine hydrochloride (7, 8 ; see Scheme 1).
All compounds were characterized by hydrogen (¹H) and carbon (¹³C) NMR. The main chemical shift s for each compound are shown in Table I . A signal at d 7.27 to 9.05 ppm in 1 H NMR spectra of all synthesized substances could be observed and was att ributed to H from imine, since this position is highly deshielded due to the induced anisotropy generated by the bound aromatic ring and the imine double bond. In 13 C NMR spectra, the signal related to the imine carbon is usually seen around d 145 ppm, whereas the signal ranging from d 155 to 175 ppm is associated with the highly deshielded quaternary carbon of guanidine moiety.
The cell lines were exposed to derivatives guanylhydrazones (0-5 mmol L . Introduction of an electron-donor group such as hydroxyl or methoxyl 4, 5, 6 and 7 at ortho-and/or para-position did not increase the cytotoxic activity. However, bridging between two groups in 9 induced a slight increase in activity towards the MDA-MB-435 cell line (Table II) .
Replacement of the electron-donor group by electron-withdrawing polar groups such as nitrile 3 or formyl 11 showed no signifi cant improvement in potency relative to the parent phenyl group. Introduction of halogen atoms signifi cantly enhanced the activity, as seen in compounds 2, 8 and 18.
Compound 6 has shown higher selectivity against MDA-MB-435 than the other two cell lines. This facts, may be related to hydroxyl at position 3 in the phenyl ring, showing superior activity compared to the compound 4.
A signifi cant increase in cytotoxic activity was observed, when chlorine was introduced in para-position, since compound 2 was found more potent than 18 (meta-position). However, disubstituted 3,4-dichloro analogue 17 led to bett er activity, with 100 % inhibition of tumor cell lines at 5 mmol L -1 . Interestingly, guanabenz (trade name, Wintensy ® ) 12, a drug developed as an alpha-2 adrenergic agonist was signifi cantly less active than compound 19.
Introduction of a second phenyl ring at para-14 or ortho-19 position led to a set of more potent compounds. This eff ect highlights the importance of the lipophilic character, which probably plays an important role in cytotoxic activity. In this sense, compound 10 was also highly active, since the presence of the bulky tert-butyl groups increased lipophilic character to the molecule, resulting in the best compound of the series.
Finally, the replacement of the phenyl ring by a heteroaromatic ring as in 1 and 13 led to activity decrease compared to compound 15.
The most powerful compounds recognized in cytotoxic assays against human cancer cell lines at 5 mmol L -1 (Table II) were tested to obtain IC 50 values, which were compared to those of doxorubicin (control), as shown in Table III . Each assay was carried out in dupliScheme 1 tion and data obtained are displayed in Fig. 2 . Results suggest that 10 shows low toxicity to non-tumor cells, because it is only able to decrease cell viability at a high concentration of 1 mmol L -1
. The other three compounds, 14, 17 and 19, showed higher cytotoxicity for non-tumor cells since they reduced cell viability at all tested concentrations (10, 100 and 1000 mmol L -1 ). This confi rms that compound 10 acts selectively on tumor cell lines and bears the most promising profi le regarding cytotoxic activity. 
CONCLUSIONS
The results reported in this study indicate that lipophilic guanylhydrazones 10, 14, 17 and 19 showed the highest cytotoxic activity against diff erent human cancer cell lines. Compound 10 showed higher selectivity towards tumor cell lines and therefore it may be considered promising for the development of novel cytotoxic agents based on this scaff old.
